Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Overexpression Of Mitochondrial Transcription Factor A Ameliorates Mitochondrial Deficiencies And Cardiac Failure After Myocardial Infarction.
M. Ikeuchi, H. Matsusaka, D. Kang, S. Matsushima, T. Ide, T. Kubota, T. Fujiwara, N. Hamasaki, A. Takeshita, K. Sunagawa, H. Tsutsui
Published 2005 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
BACKGROUND Mitochondrial DNA (mtDNA) copy number is decreased not only in mtDNA-mutation diseases but also in a wide variety of acquired degenerative and ischemic diseases. Mitochondrial transcription factor A (TFAM) is essential for mtDNA transcription and replication. Myocardial mtDNA copy number and TFAM expression both decreased in cardiac failure. However, the functional significance of TFAM has not been established in this disease state. METHODS AND RESULTS We have now addressed this question by creating transgenic (Tg) mice that overexpress human TFAM gene and examined whether TFAM could protect the heart from mtDNA deficiencies and attenuate left ventricular (LV) remodeling and failure after myocardial infarction (MI) created by ligating the left coronary artery. TFAM overexpression could ameliorate the decrease in mtDNA copy number and mitochondrial complex enzyme activities in post-MI hearts. Survival rate during 4 weeks of MI was significantly higher in Tg-MI than in wild-type (WT) littermates (WT-MI), although infarct size was comparable. LV cavity dilatation and dysfunction were significantly attenuated in Tg-MI. LV end-diastolic pressure was increased in WT-MI, and it was also reduced in Tg-MI. Improvement of LV function in Tg-MI was accompanied by a decrease in myocyte hypertrophy, apoptosis, and interstitial fibrosis as well as oxidative stress in the noninfarcted LV. CONCLUSIONS Overexpression of TFAM inhibited LV remodeling after MI. TFAM may provide a novel therapeutic strategy of cardiac failure.
This paper references
Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart.
A. Kanazawa (2002)
Regulation of mitochondrial transcription by mitochondrial transcription factor A
Julio Montoya (2004)
Inhibition of mitochondrial gene expression by antisense RNA of mitochondrial transcription factor A (mtTFA)
H. Inagaki (1998)
Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice
N. Larsson (1998)
Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium.
T. Ide (1999)
Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy.
E. Arbustini (1998)
Regulation of mitochondrial D‐loops by transcription factor A and single‐stranded DNA‐binding protein
C. Takamatsu (2002)
Similarity of human mitochondrial transcription factor 1 to high mobility group proteins.
M. Parisi (1991)
Replication and transcription of vertebrate mitochondrial DNA.
D. Clayton (1991)
Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction
T. Ide (2001)
Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy.
H. Li (2000)
Mitochondrial diseases in man and mouse.
D. Wallace (1999)
Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1
Z. Wu (1999)
The relationship between somatic mtDNA rearrangements, human heart disease and aging.
O. Kajander (2002)
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.
J. Lin (2002)
Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria.
W. Lewis (1992)
Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor
F. Naya (2002)
Biogenesis of Mitochondria
D. Haldar (1966)
Efficient selection for highexpression transfectants with a novel eukaryotic
H Niwa (1991)
Overexpression of Glutathione Peroxidase Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice
T. Shiomi (2004)
Nuclear receptor signaling and cardiac energetics.
J. Huss (2004)
Nuclear activators and coactivators in mammalian mitochondrial biogenesis.
R. Scarpulla (2002)
Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease.
M. Corral-Debrinski (1992)
Time-Dependent and Tissue-Specific Accumulation of mtDNA and Respiratory Chain Defects in Chronic Doxorubicin Cardiomyopathy
D. Lebrecht (2003)
mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases.
C. Moraes (1991)
Mitochondrial DNA maintenance in vertebrates.
G. Shadel (1997)
Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects.
R. Anan (1995)
Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression
J. Wang (1999)
Energy metabolism in heart failure
R. Ventura-Clapier (2004)
Human mitochondrial DNA is packaged with TFAM.
Tanfis Istiaq Alam (2003)
Efficient selection for high-expression transfectants with a novel eukaryotic vector.
H. Niwa (1991)
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles
A. Garnier (2003)
Cardiac-Specific Induction of the Transcriptional Coactivator Peroxisome Proliferator-Activated Receptor &ggr; Coactivator-1&agr; Promotes Mitochondrial Biogenesis and Reversible Cardiomyopathy in a Developmental Stage-Dependent Manner
Laurie K. Russell (2004)
Mitochondrial transcription factor A regulates mtDNA copy number in mammals.
Mats I Ekstrand (2004)
Pioglitazone, a Peroxisome Proliferator-Activated Receptor-&ggr; Agonist, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction
T. Shiomi (2002)
Timedependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation
D Lebrecht (2003)
This paper is referenced by
Implication des toxiques environnementaux dans la régulation mitochondriale et pathologies associées
M. Benarbia (2012)
Overexpression of mitochondrial transcription factor A (TFAM) ameliorates delayed neuronal death due to transient forebrain ischemia in mice
M. Hokari (2010)
Mitochondrial Transcription Factors TFA, TFB1 and TFB2: A Search for DNA Variants/Haplotypes and the Risk of Cardiac Hypertrophy
C. Alonso-Montes (2008)
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats
F. Forini (2011)
Mitochondria and PGC-1α in Aging and Age-Associated Diseases
T. Wenz (2011)
Peroxisome Proliferator–Activated Receptor γ Coactivator-1 (PGC-1) Regulatory Cascade in Cardiac Physiology and Disease
B. Finck (2007)
Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer’s disease
S. Oka (2016)
Regulation of mitochondrial biogenesis through TFAM-mitochondrial DNA interactions: Useful insights from aging and calorie restriction studies.
A. Picca (2015)
PGC-1 Coactivators in Cardiac Development and Disease
G. Rowe (2010)
Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases
H. Nakayama (2018)
Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice
E. Ylikallio (2010)
The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms
I. Kang (2018)
Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine
J. Wang (2015)
Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis
Xiaochao Tian (2017)
Defective DNA Replication Impairs Mitochondrial Biogenesis In Human Failing Hearts
Georgios Karamanlidis (2010)
Expression and Methylation of Mitochondrial Transcription Factor A in Chronic Obstructive Pulmonary Disease Patients with Lung Cancer
H. Peng (2013)
Biological Markers of Oxidative Stress in Cardiovascular Diseases: After so Many Studies, What do We Know?
J. Fontana (2018)
p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities
J. Li (2019)
Chronic Arsenic Exposure-Induced Oxidative Stress is Mediated by Decreased Mitochondrial Biogenesis in Rat Liver
C. Prakash (2016)
Molecular regulation of the cardiac-enriched acetyl-CoA carboxylase isoform (ACCβ) : a novel target for therapeutic interventions in cardiovascular disease
S. Makaula (2006)
Targeting mitochondrial biogenesis for promoting health
G. Stefano (2012)
Targeting the Redox System to Overcome Mechanisms of Drug Resistance in Chronic Lymphocytic Leukemia
M. Ogasawara (2014)
The Effect of Short-Term Treadmill Exercise on the Expression Level of TFAM in the Heart of Nicotine-Sensitized Rats
Amir Lashgari (2020)
Impaired Mitochondrial Biogenesis Precedes Heart Failure in Right Ventricular Hypertrophy in Congenital Heart Disease
Georgios Karamanlidis (2011)
Developmental and Pathological Changes in the Human Cardiac Muscle Mitochondrial DNA Organization, Replication and Copy Number
J. Pohjoismäki (2010)
A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling
L. Schirone (2017)
Mitochondrial dysfunction and altered ribostasis in hippocampal neurons with cytoplasmic inclusions of multiple system atrophy
Norihisa Maeda (2018)
Mouse models of mitochondrial DNA defects and their relevance for human disease
H. Tyynismaa (2009)
Effect of mitochondrial transcription factor a overexpression on motor neurons in amyotrophic lateral sclerosis model mice
N. Morimoto (2012)
The Overexpression of Twinkle Helicase Ameliorates the Progression of Cardiac Fibrosis and Heart Failure in Pressure Overload Model in Mice
A. Tanaka (2013)
Resveratrol Attenuates Exercise-Induced Adaptive Responses in Rats Selectively Bred for Low Running Performance
N. Hart (2014)
Mitochondria as Key Targets of Cardioprotection in Cardiac Ischemic Disease: Role of Thyroid Hormone Triiodothyronine
F. Forini (2015)See more